Cardiovascular Pathology
Volume 20, Issue 2 , Pages 114-123, March 2011

Animal models of abdominal aortic aneurysm and their role in furthering management of human disease

Received 2 September 2009; received in revised form 2 November 2009; accepted 4 January 2010. published online 05 February 2010.

Abstract 

Abdominal aortic aneurysm is a common degenerative disorder associated with sudden death due to aortic rupture. Current therapy is limited to open surgical repair of the aorta or endovascular placement of covered stents to exclude the abdominal aortic aneurysm from the circulation. A number of different animal models have been developed in order to study abdominal aortic aneurysm in an effort to advance current management deficiencies. Large animal models have been mostly used to assist in developing novel methods to surgically treat abdominal aortic aneurysms. Small animal models, particularly those developed in rodents, have been employed to further the understanding of the mechanisms involved in abdominal aortic aneurysm in order to identify potential new medical treatments. It is expected that findings from these animal models will contribute importantly to new treatments for human abdominal aortic aneurysm. This review explores the animal models which are used in abdominal aortic aneurysm research and highlights their advantages and disadvantages.

Keywords: Abdominal aortic aneurysm, Animal models, Drug development

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Financial support: This work was supported by funding from the National Health and Medical Research Council, Australia (project grant number 540405). Jonathan Golledge holds a Practitioner's Fellowship from the National Health and Medical Research Council, Australia (grant number 431503).

PII: S1054-8807(10)00002-5

doi:10.1016/j.carpath.2010.01.001

Cardiovascular Pathology
Volume 20, Issue 2 , Pages 114-123, March 2011